Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

Impact · against what's priced in

The article provides no new material catalysts for Pfizer, as the Seagen acquisition, recent regulatory approvals, and the decline in COVID-related revenue are all well-known factors already reflected in the stock's 34% five-year decline. The dividend yield is a function of this price drop rather than a new fundamental driver.

PFE+0.00: No priced-in read yet

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

What matters in this story

Vanda says anxiety drug failed main goal of late-stage study, puts program on hold

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

What matters in this story

Vanda says anxiety drug failed main goal of late-stage study, puts program on hold

How each ticker is affected

Connected tickers

Track these names every morning.

Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Can The Hartford's Equitable Deal Strengthen Its Benefits Business?

Walmart Stock Moves Higher: What's Happening?

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

What matters in this story

Next reads from the same story arc

Vanda says anxiety drug failed main goal of late-stage study, puts program on hold

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

What matters in this story

Next reads from the same story arc

Vanda says anxiety drug failed main goal of late-stage study, puts program on hold

How each ticker is affected

Connected tickers

Track these names every morning.

Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Can The Hartford's Equitable Deal Strengthen Its Benefits Business?

Walmart Stock Moves Higher: What's Happening?